FDA warned M Six Labs over unapproved CBD/Delta-8 THC drugs, illegal CBD/Delta-8 foods, and animal drugs sold online.
What happened
FDA reviewed https://m6labs.com in February 2022 and found the company took orders for human and animal products represented as containing CBD or Delta-8 THC. FDA said website claims—such as cancer, anxiety, pain, seizures, and inflammation—made the human products unapproved new drugs. The letter also cites CBD and Delta-8 THC in foods and CBD products for animals.
What FDA found
Human CBD and Delta-8 THC products were marketed with claims to treat or prevent disease, making them unapproved drugs.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)The human products' labeling lacked adequate directions for use, which FDA calls misbranded.
FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1)CBD and Delta-8 THC added to food were unsafe food additives, making those foods adulterated (illegal because they contain an unsafe additive).
FD&C Act section 402(a)(2)(C)(i), 21 U.S.C. 342(a)(2)(C)(i)CBD added to food was also a prohibited act under the FD&C Act.
FD&C Act section 301(ll), 21 U.S.C. 331(ll)CBD products for animals were unapproved animal drugs and were unsafe and illegal under the drug law.
FD&C Act sections 512(a) and 501(a)(5), 21 U.S.C. 360b(a) and 351(a)(5)CBD products marketed as dietary supplements did not meet the legal definition of a dietary supplement.
FD&C Act sections 201(ff)(3)(B)(i) and (ii), 21 U.S.C. 321(ff)(3)(B)(i) and (ii)
What FDA wants
FDA asks the company to notify FDA in writing within 15 working days of steps taken to correct the violations and prevent recurrence, or to explain any delay and give a completion date.
Who should pay attention
- retailers and distributors selling CBD or Delta-8 THC products
- brands making CBD or Delta-8 foods, supplements, or pet products
- contract manufacturers and labs testing cannabinoid products
This is a summary. Read the original letter on fda.gov.